Search Results - "Allen, Pamela Blair"
-
1
Association of insurance status and race with overall survival among patients with cutaneous T-cell lymphoma: A National Cancer DataBase analysis
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
2
T-cell receptor gene rearrangement clonality, flow cytometry status, and associated outcomes in early-stage CTCL
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e20087 Background: Cutaneous T-Cell Lymphoma (CTCL) is a monoclonal lymphoproliferative disease. Studies hypothesize T-cell receptor gene (TCR)…”
Get full text
Journal Article -
3
Evidence-Based Minireview: What is the optimal timing of anti-PD-1 antibodies in relapsed classical Hodgkin lymphoma?
Published in Hematology (06-12-2019)“…A 26-year-old woman was initially diagnosed with stage III classical Hodgkin lymphoma (HL) treated with doxorubicin, bleomycin, vinblastine, and dacarbazine…”
Get full text
Journal Article -
4
-
5
Investigating the impact of demographic disparities on clinical outcomes in cutaneous T-cell lymphoma (CTCL): A multicenter retrospective cohort analysis
Published in Journal of clinical oncology (01-06-2023)“…7573 Background: Black patients have been shown to have a higher incidence of cutaneous T-cell lymphomas (CTCL) and display unique clinicopathologic features…”
Get full text
Journal Article -
6
Association of geographic clustering of cutaneous T-cell lymphoma in the state of Georgia with environmental exposure to benzene and trichloroethylene
Published in Journal of clinical oncology (20-05-2019)“…Abstract only 1551 Background: Geographic clustering of CTCL has been recently reported in large registries, but its association with environment factors is…”
Get full text
Journal Article -
7
PD-1 blockade in Hodgkin's lymphoma: learning new tricks from an old teacher
Published in Expert review of hematology (02-10-2016)“…Classical Hodgkin's Lymphoma (cHL) is characterized by genetic reliance on the PD-1 pathway. Rapid accumulation of data describing the role and efficacy of…”
Get more information
Journal Article -
8
Impact of individual comorbidities on post-transplant outcomes for elderly patients with non-Hodgkin lymphoma (NHL)
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
9
Average Time to Treatment in Lymphoma Patients Undergoing Ovarian Preservation: Experience from a Single Institution
Published in Blood (03-12-2015)“…Background: Cryopreservation of oocytes or fertilized embryos prior to initiation of chemotherapy offers women with cancer an opportunity for future pregnancy…”
Get full text
Journal Article -
10
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma
Published in Blood advances (26-12-2023)“…In the pivotal study ECHELON-1, brentuximab vedotin (BV), doxorubicin, vinblastine, and dacarbazine (A + AVD) demonstrated superior efficacy compared with…”
Get full text
Journal Article